Matrix Capital Management Company, LP
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Matrix Capital Management Company, LP reported 23 stock positions worth $10.8 billion. Its top holding was Nvidia (NVDA) at 22.3% of the portfolio, followed by Transdigm (TDG, 12.5%) and Qualcomm (QCOM, 10.9%). Compared with Q4 2023, it opened 6 new positions, sold out of 2, added to 3 and reduced 4. The biggest buy was a new position in Qualcomm (QCOM) and the biggest sale an exit from Applied Materials (AMAT).
- Most Recent 13F
- Q2 2026
- Location
- Portsmouth, NH
- CIK
- 0001410830
- Portfolio Value
- $10.8B (Q1 2024)
- SEC Filing
- 0001172661-24-002306 ↗ filed May 14, 2024
Holdings Value
Holdings 23 stocks · $10.8B
| NVDA Nvidia Corp. | 22.31% | 2,658,512 | $2.4B | Reduce -19.6% |
| TDG Transdigm Group Inc. | 12.53% | 1,094,900 | $1.3B | No change |
| QCOM Qualcomm Inc. | 10.88% | 6,919,764 | $1.2B | New |
| ALTR Altair Engineering Inc. Class A | 9.95% | 12,430,000 | $1.1B | Add +1.6% |
| MRVL Marvell Technology Inc. | 9.91% | 15,055,500 | $1.1B | No change |
| GFS Globalfoundries Inc. | 8.12% | 16,779,809 | $874.4M | Reduce -1.6% |
| AMZN Amazon.com Inc. | 7.46% | 4,450,000 | $802.7M | Reduce -39.3% |
| WDAY Workday Inc. Class A | 4.02% | 1,586,043 | $432.6M | No change |
| SNPS Synopsys Inc. | 3.81% | 717,735 | $410.2M | No change |
| ASML ASML Holding NV-NY Reg SHS | 3.40% | 377,200 | $366.1M | Reduce -24.1% |
| ZNTL Zentalis Pharmaceuticals Inc. | 2.04% | 13,959,973 | $220.0M | No change |
| VEEV Veeva Systems Inc. Class A | 1.07% | 498,821 | $115.6M | Add +635.4% |
| MRNA Moderna Inc. | 0.72% | 730,000 | $77.8M | Add +60.8% |
| GOOGL Alphabet Inc. Class A | 0.70% | 500,000 | $75.5M | New |
| ADAPY Adaptimmune Therapeutics-ADR | 0.57% | 38,974,185 | $61.6M | No change |
| PTC PTC Inc. | 0.52% | 296,793 | $56.1M | New |
| PRM Perimeter Solutions SA | 0.51% | 7,462,500 | $55.4M | No change |
| AURA Aura Biosciences Inc. | 0.50% | 6,922,870 | $54.3M | No change |
| ANSS Ansys Inc. | 0.47% | 145,000 | $50.3M | New |
| ADPT Adaptive Biotechnologies | 0.35% | 11,572,590 | $37.1M | No change |
| U Unity Software Inc. | 0.06% | 250,000 | $6.7M | New |
| BBIO Bridgebio Pharma Inc. | 0.05% | 170,000 | $5.3M | New |
| ZS Zscaler Inc. | 0.03% | 18,405 | $3.5M | No change |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
| QCOM Qualcomm Inc. | New | 10.88% | +10.88 |
| VEEV Veeva Systems Inc. Class A | Add +635.4% | 1.07% | +0.94 |
| GOOGL Alphabet Inc. Class A | New | 0.70% | +0.70 |
| PTC PTC Inc. | New | 0.52% | +0.52 |
| ANSS Ansys Inc. | New | 0.47% | +0.47 |
| MRNA Moderna Inc. | Add +60.8% | 0.72% | +0.26 |
| U Unity Software Inc. | New | 0.06% | +0.06 |
| BBIO Bridgebio Pharma Inc. | New | 0.05% | +0.05 |
| ALTR Altair Engineering Inc. Class A | Add +1.6% | 9.95% | −0.65 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 1 | $46.3M | AURA |
| Q4 2025 | 2 | $57.6M | AURA, MAZE |
| Q3 2025 | 3 | $106.7M | MAZE, AURA, ZNTL |
| Q2 2025 | 4 | $222.8M | GFS, AURA, MAZE, ZNTL |
| Q1 2025 | 4 | $347.2M | GFS, AURA, MAZE, ZNTL |
| Q4 2024 | 5 | $2.2B | ALTR, GFS, PRM, AURA, ZNTL |
| Q3 2024 | 7 | $2.1B | ALTR, GFS, PRM, AURA, ZNTL |
| Q2 2024 | 23 | $13.1B | NVDA, QCOM, TDG, ALTR, MRVL |
| Q1 2024 | 23 | $10.8B | NVDA, TDG, QCOM, ALTR, MRVL |